Longevity Health Holdings Inc 's

• XAGE's Stock Performance relative to its Competitors

Vericel Corporation Share Performance +15.32% One Year

Vericel Corporation Profile Vericel Corporation's business model revolves around the development and commercialization of innovative cellular therapies for the treatment of severe diseases and conditions. More about Vericel Corporation's Market Share

Natera Inc Share Performance +40.69% This Year

Natera Inc Profile Natera Inc operates as a genetic testing company that provides non-invasive screening and diagnostic tests for reproductive health, oncology, and organ transplantation. The company's business model is built around offering cost-effective and accurate genetic testing solutions for both patients and healthcare providers. Natera primarily generates revenue by selling its proprietary tests and associated analysis services to customers, including hospitals, laboratories, and physicians. More about Natera Inc 's Market Share

Mesoblast Limited Share Performance +13.55% This Quarter

Mesoblast Limited Profile Mesoblast Ltd is a biotechnology company that operates on a business model focused on the development and commercialization of proprietary cell-based regenerative medicines. They aim to transform the treatment of various degenerative diseases by utilizing their patented technology and strategic partnerships with pharmaceutical companies. More about Mesoblast Limited's Market Share

Capricor Therapeutics inc Share Performance -64.99% This Year

Capricor Therapeutics inc Profile Capricor Therapeutics Inc's business model revolves around developing innovative regenerative medicine therapies for the treatment of diseases that have unmet medical needs. More about Capricor Therapeutics inc 's Market Share

Harvard Apparatus Regenerative Technology Inc Share Performance -12.75% One Year

Harvard Apparatus Regenerative Technology Inc Profile Biostage Inc is a company that aims to develop and commercialize bioengineered organ implants for the treatment of life-threatening conditions. They utilize their proprietary CellFrame technology to create personalized, implantable organs that can potentially restore and regenerate damaged tissue. More about Harvard Apparatus Regenerative Technology Inc 's Market Share

Sources: Longevity Health Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, August 30, 2026 2:47 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Longevity Health Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.